LG Chem Ltd.
- Address
- 128 Yeoui-Daero, Yeongdeungpo-Gu
Sponsor Overview
Specializations
Gout and Hyperuricemia
Clinical research activity is centered on gout with hyperuricemia, reflecting interest in uric acid control and treatment options for patients with persistent elevated serum urate.
- Serum urate reduction
- Gout management
- Hyperuricemia treatment
Work in this area focuses on therapies intended to improve urate-lowering outcomes in people affected by recurrent gout symptoms and metabolic uric acid imbalance.
Xanthine Oxidase Inhibition
The sponsor’s research interest includes xanthine oxidase inhibition, a key therapeutic pathway for lowering uric acid in hyperuricemia.
- Urate-lowering therapy
- Xanthine oxidase targeting
- Allopurinol comparison
This area reflects attention to pharmacologic approaches for controlling serum uric acid and supporting long-term management of gout.
Rheumatologic Metabolic Disorders
Research activity extends into rheumatologic disease linked to metabolic disturbance, with emphasis on gouty arthritis and complications associated with sustained hyperuricemia.
- Gouty arthritis
- Uric acid metabolism
- Chronic crystal arthritis
These interests align with treatment development for patients whose gout burden is driven by abnormal uric acid handling.
Oral Small-Molecule Therapy
The sponsor’s clinical program includes oral small-molecule therapy for gout, with focus on agents designed for practical long-term urate-lowering use.
- Oral therapy
- Small-molecule drugs
- Long-term urate control
Interest in this domain supports evaluation of treatment options for patients needing sustained control of serum urate in gout with hyperuricemia.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| A Randomized, Multi-regional, Double-blind, Double-dummy Parallel-group, Placebo and Allopurinol-controlled Phase 3 Study to Assess the Efficacy and Safety of Tigulixostat in Gout Patients with Hyperuricemia |  Belgium Bulgaria Czechia France Germany Italy Lithuania Poland Spain | Not Recruiting |
Data & Insights
This sponsor works with 4 molecules, of which 1 is not being studied by other sponsors.
This sponsor has worked with 69 sites across their trial portfolio.
Therapeutic Focus
- 1.Musculoskeletal Diseases1 trial238 other sponsors
- 2.Nutritional and Metabolic Diseases1 trial211 other sponsors
- 3.Pathological Conditions, Signs and Symptoms1 trial91 other sponsors
Partnered Research Centres
69 centres- Address
- Bulevard Tsarigradsko Shose 66a, 1784 Sofia
- Address
- Via Venezia 16, 15121 Alessandria
- Address
- Via Cherasco 15, 10126 Turin
- Address
- Via Del Vespro 129, 90127 Palermo
- Address
- Via Giovanni Amendola 2, 42122 Reggio Emilia
- Address
- Carrer De La Feixa Llarga S/N, 08907 L'hospitalet De Llobregat
Want to get in touch with this sponsor?
Send a question and we'll pass it on to LG Chem Ltd..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.